XML 65 R49.htm IDEA: XBRL DOCUMENT v3.25.3
Note 18 - Segment and Geographic Information (Tables)
12 Months Ended
Sep. 30, 2025
Notes Tables  
Schedule of Segment Reporting Information, by Segment [Table Text Block]
  

Year Ended September 30,

 
  

2025

  

2024

  

2023

 

Revenue:

            

Sample Management Solutions

 $324,590  $318,896  $303,190 

Multiomics

  269,231   254,552   248,296 

Total revenue

 $593,821  $573,448  $551,486 
             

Adjusted operating income (loss):

            

Sample Management Solutions

 $27,550  $11,106  $(2,293)

Multiomics

  (11,937)  (7,733)  (13,337)

Segment adjusted operating income (loss)

  15,613   3,373   (15,630)
             

Amortization of completed technology

  7,965   8,066   7,847 

Amortization of intangible assets other than completed technology

  16,475   20,496   24,221 

Transformation(1) and rebranding costs

  10,405   9,879   (49)

Restructuring charges

  5,171   6,766   4,577 

Impairment of goodwill and intangible assets

     4,658    

Merger and acquisition costs and costs related to share repurchase(2)

  2,403   4,874   8,962 

Other miscellanous expenses

  38   (82)  58 

Total operating loss

  (26,844)  (51,284)  (61,246)

Interest income, net

  18,779   32,891   43,541 

Other income (expense), net

  922   (732)  (2,300)

Loss from continuing operations before income taxes

 $(7,143) $(19,125) $(20,005)
Schedule of Segment Reporting, Adjusted Cost of Revenues [Table Text Block]

Sample Management Solutions

 

Year Ended September 30,

 
  

2025

  

2024

  

2023

 
             

Total revenue

 $324,590  $318,896  $303,190 

Less: Adjusted cost of revenue

  163,345   173,173   169,106 

Less: Adjusted operating expenses

  133,695   134,617   136,377 

Adjusted operating income (loss)

 $27,550  $11,106  $(2,293)
             

Other Information

            

Depreciation Expense

 $11,457  $10,708  $10,527 

Multiomics

 

Year Ended September 30,

 
  

2025

  

2024

  

2023

 
             

Total revenue

 $269,231  $254,552  $248,296 

Less: Adjusted cost of revenue

  152,161   137,230   135,324 

Less: Adjusted operating expenses

  129,007   125,055   126,309 

Adjusted operating income (loss)

 $(11,937) $(7,733) $(13,337)
             
             

Other Information

            

Depreciation Expense

 $15,249  $14,486  $14,208 
Reconciliation of Assets from Segment to Consolidated [Table Text Block]

Assets:

 

September 30, 2025

  

September 30, 2024

  

September 30, 2023

 

Sample Management Solutions

 $854,402  $849,418  $675,247 

Multiomics

  445,212   462,825   534,437 

Total assets

 $1,299,614  $1,312,243  $1,209,684 
  

September 30,

  

September 30,

  

September 30,

 
  

2025

  

2024

  

2023

 

Segment assets

 $1,299,614  $1,312,243  $1,209,684 

Cash and cash equivalents, restricted cash, and marketable securities

  546,201   490,707   1,104,827 

Deferred tax assets

  726   837   657 

General corporate assets

  54,500   23,632   28,024 

Assets held for sale

  158,541   272,846   542,153 

Total assets

 $2,059,582  $2,100,265  $2,885,345 
Schedule of Revenue from External Customers Attributed to Foreign Countries by Geographic Area [Table Text Block]
  

Year Ended September 30,

 
  

2025

  

2024

  

2023

 

Geographic Location:

            

United States

 $365,003  $365,054  $351,405 

China

  58,347   58,242   52,131 

United Kingdom

  35,388   27,204   26,660 

Rest of Europe

  107,370   95,154   87,186 

Asia Pacific

  23,280   21,320   25,630 

Other

  4,433   6,474   8,474 

Total revenue

 $593,821  $573,448  $551,486 
Schedule of Disclosure on Geographic Areas, Long-Lived Assets in Individual Foreign Countries by Country [Table Text Block]
  

September 30,

 
  

2025

  

2024

 

United States

 $116,681  $122,506 

China

  56,715   54,918 

Europe

  31,012   34,300 

Asia Pacific

  3,505   4,140 

Other

  89   164 

Total long-lived assets, net

 $208,002  $216,028